β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals

Neurobiology of Aging

Volumn 40, Issue , 2016, Pages 173-180

  Fletcher, Evan ^a   Villeneuve, Sylvia ^b   Maillard, Pauline ^a   Harvey, Danielle ^a   Reed, Bruce ^a   Jagust, William ^c   DeCarli, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's; Atrophy; Longitudinal; Neurodegeneration; Normals; amyloid

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN DEGENERATION; BRAIN REGION; BRAIN SIZE; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; ATROPHY; DIAGNOSTIC IMAGING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGY; REGRESSION ANALYSIS; VASCULAR AMYLOIDOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; CEREBRAL AMYLOID ANGIOPATHY; COGNITION; COHORT STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; REGRESSION ANALYSIS;

EID: 84958542310     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.01.133     Document Type: Article

References (46)

1. Acosta-Cabronero J., Nestor P.J. Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations. Front. Aging Neurosci. 2014, 6:266.
2. Acosta-Cabronero J., Williams G.B., Pengas G., Nestor P.J. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 2010, 133:529-539.
3. Aljabar P., Heckemann R.A., Hammers A., Hajnal J.V., Rueckert D. Multi-atlas based segmentation of brain images: atlas selection and its effect on accuracy. Neuroimage 2009, 46:726-738.
4. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. 1996, 94:3-12.
5. Buades A., Coll B., Morel J.M. A review of image denoising Algorithms, with A New one. Multiscale Model. Simul. 2005, 4:490-530.
6. Burgmans S., van Boxtel M.P.J., Gronenschild E.H.B.M., Vuurman E.F.P.M., Hofman P., Uylings H.B.M., Jolles J., Raz N. Multiple indicators of age-related differences in cerebral white matter and the modifying effects of hypertension. Neuroimage 2010, 49:2083-2093.
7. Catheline G., Periot O., Amirault M., Braun M., Dartigues J.F., Auriacombe S., Allard M. Distinctive alterations of the cingulum bundle during aging and Alzheimer's disease. Neurobiol. Aging 2010, 31:1582-1592.
8. Chételat G., Landeau B., Salmon E., Yakushev I., Bahri M.A., Mézenge F., Perrotin A., Bastin C., Manrique A., Scheurich A., Scheckenberger M., Desgranges B., Eustache F., Fellgiebel A. Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity. Neuroimage 2013, 76:167-177.
9. Coupé P., Yger P., Prima S., Hellier P., Kervrann C. An optimized Blockwise non local means denoising Filter for 3D Magnetic Resonance images an optimized Blockwise non local means denoising Filter for 3D Magnetic Resonance images. IEEE Trans. Med. Imaging 2008, 27:425-441.
10. Crary J.F., Trojanowski J.Q., Schneider J.A., Abisambra J.F., Abner E.L., Alafuzoff I., Arnold S.E., Attems J., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., Gearing M., Grinberg L.T., Hof P.R., Hyman B.T., Jellinger K., Jicha G.A., Kovacs G.G., Knopman D.S., Kofler J., Kukull W.A., Mackenzie I.R., Masliah E., McKee A., Montine T.J., Murray M.E., Neltner J.H., Santa-Maria I., Seeley W.W., Serrano-Pozo A., Shelanski M.L., Stein T., Takao M., Thal D.R., Toledo J.B., Troncoso J.C., Vonsattel J.P., White C.L., Wisniewski T., Woltjer R.L., Yamada M., Nelson P.T. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014, 128:755-766.
11. Desikan R.S., Ségonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
12. Fletcher E. Using prior information to enhance sensitivity of longitudinal brain change computation. Frontiers of Medical Imaging 2014, 63-81. World Scientific: Singapore. C.H. Chen (Ed.).
13. Fletcher E., Carmichael O., Pasternak O., Maier-Hein K.H., DeCarli C. Early brain loss in circuits affected by Alzheimer's disease is predicted by fornix microstructure but may be independent of Gray matter. Front. Aging Neurosci. 2014, 6:1-9.
14. Fletcher E., Knaack A., Singh B., Lloyd E., Wu E., Carmichael O., Decarli C. Combining boundary-based methods with tensor-based morphometry in the measurement of longitudinal brain change. IEEE Trans. Med. Imaging 2013, 32:223-236.
15. Fletcher E., Singh B., Harvey D., Carmichael O., DeCarli C. Adaptive image segmentation for robust measurement of longitudinal brain tissue change. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2012, 2012:5319-5322.
16. Hua X., Leow A., Parikshak N., Lee S., Chiang M., Toga A., Jackjr C., Weiner M., Thompson P. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. NeuroImage 2008, 43:458-469.
17. Ishii K., Ishii K., Sasaki H., Sasaki H., Kono A.K., Kono A.K., Miyamoto N., Miyamoto N., Fukuda T., Fukuda T., Mori E., Mori E. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:959-963.
18. Jack C.R. PART and SNAP. Acta Neuropathol. 2014, 128:773-776.
19. Jack C.R., Holtzman D.M. Biomarker modeling of Alzheimer's disease. Neuron 2013, 80:1347-1358.
20. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
21. Jack C.R., Knopman D.S., Weigand S.D., Wiste H.J., Vemuri P., Lowe V., Kantarci K., Gunter J.L., Senjem M.L., Ivnik R.J., Roberts R.O., Rocca W.A., Boeve B.F., Petersen R.C. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann. Neurol. 2012, 71:765-775.
22. Jack C.R., Wiste H.J., Knopman D.S., Vemuri P., Mielke M.M., Weigand S.D., Senjem M.L., Gunter J.L., Lowe V., Gregg B.E., Pankratz V.S., Petersen R.C. Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology 2014, 82:1605-1612.
23. Kantarci K., Schwarz C.G., Reid R.I., Przybelski S.A., Lesnick T.G., Zuk S.M., Senjem M.L., Gunter J.L., Lowe V., Machulda M.M., Knopman D.S., Petersen R.C., Jack C.R. White matter integrity determined with diffusion tensor imaging in older adults without Dementia: influence of amyloid load and neurodegeneration. JAMA Neurol. 2014, 71:1547-1554.
24. Kochunov P., Lancaster J.L., Thompson P., Woods R., Mazziotta J., Hardies J., Fox P. Regional spatial normalization: toward and optimal target. J. Comput. Assist. Tomogr. 2001, 25:805-816.
25. Lee D., Fletcher E., Carmichael O., Singh B., Mungas D., Reed B.R., Martinez O., Buonocore M., Persianinova M., Decarli C. Sub-regional hippocampal injury is associated with fornix degeneration in Alzheimer's disease. Front. Aging Neurosci. 2012, 4:1-10.
26. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
27. Mathis C.A., Mathis C.A., Wang Y.M., Wang Y.M., Holt D.P., Holt D.P., Huang G.F., Huang G.F., Debnath M.L., Debnath M.L., Klunk W.E., Klunk W.E. Synthesis and evaluation of C-11-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 2003, 46:2740-2754.
28. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
29. Mielke M.M., Kozauer N.A., Chan K.C.G., George M., Toroney J., Zerrate M., Bandeen-Roche K., Wang M.C., Vanzijl P., Pekar J.J., Mori S., Lyketsos C.G., Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009, 46:47-55.
30. Mormino E.C., Betensky R.A., Hedden T., Schultz A.P., Amariglio R.E., Rentz D.M., Johnson K.A., Sperling R.A. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014, 71:1379.
31. Mungas D., Beckett L., Harvey D., Farias S.T., Carmichael O., Olichney J., Miller J., Decarli C. Heterogeneityof cognitive trajectories in diverse older person. Psychol. Aging 2011, 25:606-619.
32. Nestor P.J., Fryer T.D., Smielewski P., Hodges J.R. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 2003, 54:343-351.
33. Nichols T., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2001, 15:1-25.
34. Pengas G., Hodges J.R., Watson P., Nestor P.J. Focal posterior cingulate atrophy in incipient Alzheimer's disease. Neurobiol. Aging 2010, 31:25-33.
35. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256:183-194.
36. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., Holt D.P., Meltzer C.C., DeKosky S.T., Mathis C.A. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 2005, 25:1528-1547.
37. Putnam M.C., Steven M.S., Doron K.W., Riggall A.C., Gazzaniga M.S. Cortical projection topography of the human splenium: hemispheric asymmetry and individual differences. J. Cogn. Neurosci. 2010, 22:1662-1669.
38. Rueckert D., Aljabar P., Heckemann R.A., Hajnal J.V., Hammers A. Diffeomorphic registration using b-splines. Med. Image Comput. Comput. Assist. Interv. 2006, 4191:702-709.
39. Studholme C., Cardenas V. An Intensity Consistent Approach to the Cross Sectional Analysis of Deformation Tensor Derived Maps of Brain Shape. Med. Image Comput. Comput. Assist. Interv. 2002, 2488:492-499.
40. Studholme C., Cardenas V., Maudsley A., Weiner M. An intensity consistent filtering approach to the analysis of deformation tensor derived maps of brain shape. Neuroimage 2003, 19(4):1638-1649.
41. Thomas A.G., Koumellis P., Dineen R.A. The fornix in health and disease: an imaging review. Radiographics 2011, 31:1107-1121.
42. Villemagne V.L., Burnham S., Bourgeat P., Brown B., Ellis K.A., Salvado O., Szoeke C., Macaulay S.L., Martins R., Maruff P., Ames D., Rowe C.C., Masters C.L. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013, 12:357-367.
43. Villeneuve S., Rabinovici G.D., Cohn-Sheehy B.I., Madison C., Ayakta N., Ghosh P.M., Joie R.L., Arthur-Bentil S.K., Vogel J.W., Marks S.M., Lehmann M., Rosen H.J., Reed B., Olichney J., Boxer A.L., Miller B.L., Borys E., Jin L.W., Huang E.J., Grinberg L.T., Decarli C., Seeley W.W., Jagust W. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 2015, 138(Pt 7):1-14.
44. Villeneuve S., Reed B.R., Madison C.M., Wirth M., Marchant N.L., Kriger S., Mack W.J., Sanossian N., DeCarli C., Chui H.C., Weiner M.W., Jagust W.J. Vascular risk and Ab interact to reduce cortical thickness in AD vulnerable brain regions. Neurology 2014, 83:40-47.
45. Wang P.J., Saykin A.J., Flashman L.A., Wishart H.A., Rabin L.A., Santulli R.B., McHugh T.L., MacDonald J.W., Mamourian A.C. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiol. Aging 2006, 27:1613-1617.
46. Wirth M., Oh H., Mormino E.C., Markley C., Landau S.M., Jagust W.J. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement. 2013, 9:687-698.